APA (7th ed.) Citation

Weisshof, R., Vavricka, S. R., Pouillon, L., Braegger, F., Roset, M., Bent-Ennakhil, N., & Ferrante, M. (2023, November). Effectiveness and safety of vedolizumab induction with or without budesonide in patients with moderately to severely active Crohn’s disease in Europe: A retrospective observational study. BMC Gastroenterology.

Chicago Style (17th ed.) Citation

Weisshof, Roni, Stephan R. Vavricka, Lieven Pouillon, Fiona Braegger, Montserrat Roset, Nawal Bent-Ennakhil, and Marc Ferrante. "Effectiveness and Safety of Vedolizumab Induction with or Without Budesonide in Patients with Moderately to Severely Active Crohn’s Disease in Europe: A Retrospective Observational Study." BMC Gastroenterology Nov. 2023.

MLA (9th ed.) Citation

Weisshof, Roni, et al. "Effectiveness and Safety of Vedolizumab Induction with or Without Budesonide in Patients with Moderately to Severely Active Crohn’s Disease in Europe: A Retrospective Observational Study." BMC Gastroenterology, Nov. 2023.